Martine Rothblatt's SEC Filing for United Therapeutics Corp

Martine Rothblatt, the Founder, Chairperson, and Chief Executive Officer of United Therapeutics Corp, has filed a Form 144 with the SEC. The filing details the sale of 4,000 common shares on October 27, 2025, with an aggregate market value of $1,662,173.20. The securities were acquired on March 15, 2016, through Executive Deferred Compensation. The filing also includes a comprehensive list of securities sold in the past three months, totaling 104,000 shares with gross proceeds exceeding $17 million. The transactions were executed through TD Securities (USA) LLC. The filing indicates that there are 45,230,000 common shares outstanding.